- Home
- RVPHW vs DTSTW Comparison
RVPHW vs DTSTW Comparison
Compare RVPHW & DTSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- DTSTW
- Stock Information
- Founded
- RVPHW 2018
- DTSTW 2001
- Country
- RVPHW United States
- DTSTW United States
- Employees
- RVPHW N/A
- DTSTW N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- DTSTW EDP Services
- Sector
- RVPHW Health Care
- DTSTW Technology
- Exchange
- RVPHW Nasdaq
- DTSTW Nasdaq
- Market Cap
- RVPHW N/A
- DTSTW N/A
- IPO Year
- RVPHW N/A
- DTSTW N/A
- Fundamental
- Price
- RVPHW $0.12
- DTSTW $0.47
- Analyst Decision
- RVPHW
- DTSTW
- Analyst Count
- RVPHW 0
- DTSTW 0
- Target Price
- RVPHW N/A
- DTSTW N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- DTSTW 2.0K
- Earning Date
- RVPHW 03-14-2025
- DTSTW 03-28-2025
- Dividend Yield
- RVPHW N/A
- DTSTW N/A
- EPS Growth
- RVPHW N/A
- DTSTW N/A
- EPS
- RVPHW N/A
- DTSTW 0.02
- Revenue
- RVPHW N/A
- DTSTW $25,143,911.00
- Revenue This Year
- RVPHW N/A
- DTSTW N/A
- Revenue Next Year
- RVPHW N/A
- DTSTW N/A
- P/E Ratio
- RVPHW N/A
- DTSTW $179.81
- Revenue Growth
- RVPHW N/A
- DTSTW 1.64
- 52 Week Low
- RVPHW $0.13
- DTSTW $0.39
- 52 Week High
- RVPHW $0.15
- DTSTW $0.52
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- DTSTW N/A
- Support Level
- RVPHW N/A
- DTSTW N/A
- Resistance Level
- RVPHW N/A
- DTSTW N/A
- Average True Range (ATR)
- RVPHW 0.00
- DTSTW 0.00
- MACD
- RVPHW 0.00
- DTSTW 0.00
- Stochastic Oscillator
- RVPHW 0.00
- DTSTW 0.00
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About DTSTW Data Storage Corporation Warrant
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.